From Models to Medicine
de KAMI Think Tank
Episode 29: What Happens When You Build AI Around the Ovary
Sobre este podcast
At KAMI Think Tank, we love cutting through the AI hype to showcase where the technology actually stands and how to use it meaningfully within the life sciences. Now, we're bringing that same clarity with our community to a brand new podcast: From Models to Medicine.
Every week, we sit down with a real practitioner in the life sciences, whether they're working in the lab, leading innovation at a biotech, or building tools to better serve scientists. We discuss how they cut through the hype of AI and practically leverage the tool in their scientific workflows. Glad to have you here.
Episódios
Os 20 episódios mais recentes de 30
- Episode 29: What Happens When You Build AI Around the Ovary · 25 minIn this episode of From Models to Medicine, we sit down with Mila Morris, founder and CEO of Nova Arc, who came to women's health not from medicine but from architecture and…
- Episode 28: The Algorithm Has a Women's Health Problem · 43 minWe sit down with Geri Stengel, Forbes contributor, founder of Ventureneer, and co-chair of the Women's Health Technology Coalition, who has spent years reporting at the…
- Episode 27: The Memory Code AI Is Starting to Crack · 33 minFor this episode, we sit down with Kristeen Pareja-Navarro, co-CEO of Engram Bio, whose path from a farming family in the Philippines to peptide engineering for Alzheimer's…
- Episode 26: Bigger Models Won't Save Biomanufacturing · 24 minWe sit down with Shawn Manchester, CEO of TripleBar, whose path from yeast DNA repair to metabolic engineering at MIT to biomanufacturing AI gave him a front-row seat to one of…
- Episode 25: The 200-Page Protocol Problem AI Is Finally Solving · 37 minIn this episode of From Models to Medicine, we sit down with Angie Schwab, CEO and founder of Trialynx, who has spent 20 years watching clinical trials run over budget, over…
- Episode 24: Beyond Correlation - Teaching AI the Rules of Biology · 28 minThis week, we sit down with Jean-Baptiste Morlot of Deep Life, who makes the case that the drug discovery field has been asking the wrong thing of its AI models…
- Episode 23: When Biologists Start Thinking Like Engineers · 31 minThis week, we sit down with Katie Lennon, CSO of Exthymic, who makes a case most bench scientists aren't ready to hear: biology isn't just a discovery discipline anymore. It's…
- Episode 22: The Model Was Never Built for Her · 45 minIn this episode of From Models to Medicine, we sit down with Mark Amouzgar, co-founder and CEO of March Health. Mark opens with a striking stat: general-purpose AI models are…
- Episode 21: Glass Box Wins - What Pharma Actually Trusts in AI · 35 minIn this episode of From Models to Medicine, we sit down with Lavanya Anandan, Head of External Innovation, West Coast at CSL, whose path from bench scientist to Merck Group…
- Episode 20: The Build vs. Buy Question Every Pharma Leader is Wrestling With · 41 minWe chat with Karl Moritz, CEO of Reliant AI, now part of Cohere, whose career took him from NLP research to McKinsey to building AI infrastructure for drug development. Karl…
- Episode 19: Flow Cytometry, Biomarkers, and the AI Patterns Nobody Is Verifying · 33 minFor this episode, we sit down with Banishree Saha, Global Biomarkers Lead at Takeda, who has worked in fields such as academic liver biology to translational biomarker work, over…
- Episode 18: Why Does mRNA Keep Breaking AI Models? · 40 minIn this episode, we sit down with Chris Nelson, an mRNA scientist at nCode Bio whose career has taken him from building blood transfusion matching tests now used by the NHS, to…
- Episode 17: Garbage Data, Toxic Exposure, and the AI Gap in Environmental Health · 41 minIn this episode of From Models to Medicine, we sit down with Sarah Daniels, an environmental health researcher, who makes the argument that the chemicals making us sick might…
- Episode 16: Why Chemistry has Held Drug Discovery Back · 38 minStan Jastrzębski is the co-founder of molecule.one and a deep learning researcher who made a deliberate pivot into synthetic chemistry. In this episode, he explains why chemistry…
- Episode 15: Stacking AI with Quantum in the Sciences · 45 minAnna Benefiel has spent over 20 years in healthcare innovation, and she's tired of watching life sciences sit on the sidelines of quantum computing. In this episode, she makes a…
- Episode 14: The Drug Discovery Problems AI Alone Can't Solve · 46 minIn this episode of From Models to Medicine, we speak with Vid Stojevic, the co-founder and CEO of Kuano, a Cambridge-based company using quantum algorithms and AI to tackle the…
- Episode 13: The Microbiome is Messier Than You Think · 30 minJenny Yang is the co-founder and CEO of Outpost Bio, where her team is working to make human microbiology computable. In this episode, she breaks down why bias in ML models is so…
- Episode 12: Your Life Sciences Data Isn't Ready for AI · 49 minBogdan Knezevic is the CEO and co-founder of Kaleidoscope Bio, and he's seen enough failed AI implementations to know where they almost always break down. In this episode, he…
- Episode 11: From the Gut to the Brain - Rethinking Parkinson's with AI · 49 minIn this episode of From Models to Medicine, we sit down with Minna Schmidt, a postdoctoral researcher at the Buck Institute for Research on Aging. Minna walks us through Braak's…
- Episode 10: When AI Gets It Wrong, Patients Pay the Price · 38 minIn this episode of From Models to Medicine, we sit down with Sal Tejani, Associate Director for Field Medical Affairs at Regeneron*, who started his career catching dangerous…








